<p>投資者標題公司（NASDAQ:ITIC - 獲取免費報告）的股價在週四的交易中突破了其 200 日移動平均線。該股票的 200 日移動平均價為 231.24 美元，最高交易價為 259.65 美元。投資者標題的股票最後交易價為 255.26 美元，成交量為 24,204 股。</p>
<p>獲取 <strong>投資者標題</strong> 的提醒：</p>
<h2>分析師升級和降級</h2>
<p>另外，Weiss Ratings 在 10 月 8 日的研究報告中重申了對投資者標題股票的 “買入（b）” 評級。一位投資分析師對該股票給予了買入評級，根據 MarketBeat 的數據，該公司的平均評級為 “買入”。</p>
<p><strong>查看我們對 ITIC 的最新分析</strong></p>
<h2>投資者標題股票表現</h2>
<p>該股票的 50 日移動平均價為 252.13 美元，200 日移動平均價為 231.24 美元。該公司的市值為 4.8244 億美元，市盈率為 14.60，貝塔值為 0.87。</p>
<p>投資者標題（NASDAQ:ITIC - 獲取免費報告）最近在 8 月 6 日宣佈了其季度財報。該保險提供商報告的每股收益（EPS）為 6.48 美元。該季度的營業收入為 7155 萬美元。投資者標題的淨利潤率為 12.28%，股本回報率為 12.70%。</p>
<h2>投資者標題宣佈分紅</h2>
<p>該公司最近還宣佈了季度分紅，已於 9 月 15 日支付。9 月 2 日的登記股東獲得了 0.46 美元的分紅。這相當於年化 1.84 美元的分紅和 0.7% 的分紅收益率。除息日為 9 月 2 日。投資者標題的分紅支付比率（DPR）目前為 10.53%。</p>
<h2>對投資者標題的對沖基金看法</h2>
<p>幾家對沖基金最近增加或減少了對該公司的持股。AlphaQuest LLC 在第二季度購買了價值約 27,000 美元的投資者標題新頭寸。Connor Clark &amp; Lunn Investment Management Ltd.在第二季度購買了價值約 224,000 美元的投資者標題新頭寸。Brevan Howard Capital Management LP 在第二季度購買了價值約 240,000 美元的投資者標題新頭寸。Trexquant Investment LP 在第一季度購買了價值約 244,000 美元的投資者標題新頭寸。最後，OMERS ADMINISTRATION Corp 在第二季度購買了價值約 275,000 美元的投資者標題新頭寸。目前 41.40% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>投資者標題公司簡介</h2>
<p>（獲取免費報告）</p>
<p>投資者標題公司從事住宅和商業產權保險的發行，涵蓋住宅、機構、商業和工業物業。該公司作為主要保險人承保土地產權保險，向業主和抵押權人提供保險；並承擔來自其他產權保險公司的再保險風險。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票而非投資者標題</li>
<li>2025 年有潛力上漲的兩隻 CRM 平台股票</li>
<li>Salesforce 期待已久的拐點已到：反彈開始！</li>
<li>投資者最重要的沃倫·巴菲特股票：他自己的股票</li>
<li>Rocket Lab USA 獲得華爾街的認可：是時候買入了嗎？</li>
<li>股票分紅削減發生，你準備好了嗎？</li>
<li>Archer 以戰略性舉措收購競爭對手的專利寶藏</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在投資者標題嗎？</h2>
<p>在考慮投資者標題之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而投資者標題並不在名單上。</p>
<p>雖然投資者標題目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得買入。</p>
<p>查看這五隻股票</p>

ITIC

<p>Investors Title (NASDAQ:ITIC) 的股票已突破其 200 日移動平均線 $231.24，目前交易價格為 $255.26，最高達到 $259.65。該公司報告了上個季度每股收益 $6.48 和營收 $7155 萬。Weiss Ratings 維持 “買入” 評級，41.40% 的股份由對沖基金持有。最近支付的季度股息為 $0.46，收益率為 0.7%。儘管前景樂觀，但一些分析師建議還有更好的投資選擇</p>

<p>Investors Title Company (NASDAQ:ITIC - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $231.24 and traded as high as $259.65. Investors Title shares last traded at $255.26, with a volume of 24,204 shares traded.</p>
<div class="lb-trans"><p>投資者標題公司（NASDAQ:ITIC - 獲取免費報告）的股價在週四的交易中突破了其 200 日移動平均線。該股票的 200 日移動平均價為 231.24 美元，最高交易價為 259.65 美元。投資者標題的股票最後交易價為 255.26 美元，成交量為 24,204 股。</p>
</div><p>Get <strong>Investors Title</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>投資者標題</strong> 的提醒：</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>Separately, Weiss Ratings restated a &#34;buy (b)&#34; rating on shares of Investors Title in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 10 月 8 日的研究報告中重申了對投資者標題股票的 “買入（b）” 評級。一位投資分析師對該股票給予了買入評級，根據 MarketBeat 的數據，該公司的平均評級為 “買入”。</p>
</div><p><strong>Check Out Our Latest Analysis on ITIC</strong></p>
<div class="lb-trans"><p><strong>查看我們對 ITIC 的最新分析</strong></p>
</div><h2>Investors Title Stock Performance</h2>
<div class="lb-trans"><h2>投資者標題股票表現</h2>
</div><p>The stock's fifty day moving average price is $252.13 and its 200-day moving average price is $231.24. The firm has a market cap of $482.44 million, a PE ratio of 14.60 and a beta of 0.87.</p>
<div class="lb-trans"><p>該股票的 50 日移動平均價為 252.13 美元，200 日移動平均價為 231.24 美元。該公司的市值為 4.8244 億美元，市盈率為 14.60，貝塔值為 0.87。</p>
</div><p>Investors Title (NASDAQ:ITIC - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The insurance provider reported $6.48 earnings per share (EPS) for the quarter. The business had revenue of $71.55 million during the quarter. Investors Title had a net margin of 12.28% and a return on equity of 12.70%.</p>
<div class="lb-trans"><p>投資者標題（NASDAQ:ITIC - 獲取免費報告）最近在 8 月 6 日宣佈了其季度財報。該保險提供商報告的每股收益（EPS）為 6.48 美元。該季度的營業收入為 7155 萬美元。投資者標題的淨利潤率為 12.28%，股本回報率為 12.70%。</p>
</div><h2>Investors Title Announces Dividend</h2>
<div class="lb-trans"><h2>投資者標題宣佈分紅</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were issued a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 2nd. Investors Title's dividend payout ratio (DPR) is currently 10.53%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了季度分紅，已於 9 月 15 日支付。9 月 2 日的登記股東獲得了 0.46 美元的分紅。這相當於年化 1.84 美元的分紅和 0.7% 的分紅收益率。除息日為 9 月 2 日。投資者標題的分紅支付比率（DPR）目前為 10.53%。</p>
</div><h2>Hedge Funds Weigh In On Investors Title</h2>
<div class="lb-trans"><h2>對投資者標題的對沖基金看法</h2>
</div><p>Several hedge funds have recently added to or reduced their stakes in the business. AlphaQuest LLC purchased a new position in Investors Title during the 2nd quarter valued at about $27,000. Connor Clark &amp; Lunn Investment Management Ltd. purchased a new position in Investors Title during the 2nd quarter valued at about $224,000. Brevan Howard Capital Management LP purchased a new position in Investors Title during the 2nd quarter valued at about $240,000. Trexquant Investment LP purchased a new position in Investors Title during the 1st quarter valued at about $244,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in Investors Title during the 2nd quarter valued at about $275,000. 41.40% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>幾家對沖基金最近增加或減少了對該公司的持股。AlphaQuest LLC 在第二季度購買了價值約 27,000 美元的投資者標題新頭寸。Connor Clark &amp; Lunn Investment Management Ltd.在第二季度購買了價值約 224,000 美元的投資者標題新頭寸。Brevan Howard Capital Management LP 在第二季度購買了價值約 240,000 美元的投資者標題新頭寸。Trexquant Investment LP 在第一季度購買了價值約 244,000 美元的投資者標題新頭寸。最後，OMERS ADMINISTRATION Corp 在第二季度購買了價值約 275,000 美元的投資者標題新頭寸。目前 41.40% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Investors Title Company Profile</h2>
<div class="lb-trans"><h2>投資者標題公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Investors Title Company engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies.</p>
<div class="lb-trans"><p>投資者標題公司從事住宅和商業產權保險的發行，涵蓋住宅、機構、商業和工業物業。該公司作為主要保險人承保土地產權保險，向業主和抵押權人提供保險；並承擔來自其他產權保險公司的再保險風險。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Investors Title</li>
<li>2 Rising CRM Platform Stocks That Can Surge Higher in 2025</li>
<li>Salesforce’s Long-Awaited Inflection is Here: Rally On!</li>
<li>The Most Important Warren Buffett Stock for Investors: His Own</li>
<li>Rocket Lab USA Receives Wall Street Validation: Time to Buy?</li>
<li>Stock Dividend Cuts Happen Are You Ready?</li>
<li>Archer Buys Rival's Patent Treasure Trove in Strategic Move</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票而非投資者標題</li>
<li>2025 年有潛力上漲的兩隻 CRM 平台股票</li>
<li>Salesforce 期待已久的拐點已到：反彈開始！</li>
<li>投資者最重要的沃倫·巴菲特股票：他自己的股票</li>
<li>Rocket Lab USA 獲得華爾街的認可：是時候買入了嗎？</li>
<li>股票分紅削減發生，你準備好了嗎？</li>
<li>Archer 以戰略性舉措收購競爭對手的專利寶藏</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Investors Title Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在投資者標題嗎？</h2>
</div><p>Before you consider Investors Title, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資者標題之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Investors Title wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而投資者標題並不在名單上。</p>
</div><p>While Investors Title currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然投資者標題目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得買入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Investors Title (NASDAQ:ITIC) 的股價已突破兩百日移動平均線 - 你是否應該賣出？